Financial Ratios CCL Products (India) Limited NSE India S.E.
Equities
CCL
INE421D01022
Food Processing
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 994.00 INR | -0.02% |
|
+0.35% | +5.27% |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.34 | 8.77 | 8.73 | 6.85 | 7.12 | |||||
Return on Total Capital | 10.12 | 9.53 | 9.46 | 7.36 | 7.82 | |||||
Return On Equity % | 18.08 | 17.48 | 19.68 | 15.77 | 17.05 | |||||
Return on Common Equity | 18.08 | 17.48 | 19.68 | 15.77 | 17.05 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 51.84 | 49.35 | 43.62 | 39.59 | 38.85 | |||||
SG&A Margin | 6.49 | 6.81 | 5.54 | 5.58 | 5.6 | |||||
EBITDA Margin % | 23.74 | 22.38 | 18.74 | 16.24 | 17.35 | |||||
EBITA Margin % | 19.78 | 18.46 | 15.71 | 12.64 | 14.23 | |||||
EBIT Margin % | 19.78 | 18.46 | 15.71 | 12.64 | 14.23 | |||||
Income From Continuing Operations Margin % | 14.63 | 13.94 | 12.96 | 9.4 | 9.97 | |||||
Net Income Margin % | 14.63 | 13.94 | 12.96 | 9.4 | 9.97 | |||||
Net Avail. For Common Margin % | 14.63 | 13.94 | 12.96 | 9.4 | 9.97 | |||||
Normalized Net Income Margin | 11.78 | 11.14 | 9.19 | 6.49 | 7.07 | |||||
Levered Free Cash Flow Margin | -0.39 | -15.32 | -13.34 | -22.48 | -10.22 | |||||
Unlevered Free Cash Flow Margin | 0.4 | -14.75 | -12.4 | -20.71 | -8.04 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.76 | 0.76 | 0.89 | 0.87 | 0.8 | |||||
Fixed Assets Turnover | 1.41 | 1.47 | 1.76 | 1.74 | 1.63 | |||||
Receivables Turnover (Average Receivables) | 4.39 | 4.73 | 5.44 | 5.66 | 5.23 | |||||
Inventory Turnover (Average Inventory) | 2.07 | 1.77 | 2.13 | 2.35 | 2.07 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.69 | 1.57 | 1.49 | 1.36 | 1.28 | |||||
Quick Ratio | 0.97 | 0.66 | 0.71 | 0.71 | 0.53 | |||||
Operating Cash Flow to Current Liabilities | 0.36 | 0.16 | 0.24 | 0.04 | 0.18 | |||||
Days Sales Outstanding (Average Receivables) | 83.23 | 77.16 | 67.05 | 64.7 | 69.76 | |||||
Days Outstanding Inventory (Average Inventory) | 176.49 | 206.16 | 171.24 | 155.68 | 176.52 | |||||
Average Days Payable Outstanding | 3.99 | 13.04 | 17.75 | 17.48 | 27.03 | |||||
Cash Conversion Cycle (Average Days) | 255.73 | 270.27 | 220.54 | 202.9 | 219.25 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 51.43 | 52.03 | 62.04 | 96.92 | 92.25 | |||||
Total Debt / Total Capital | 33.96 | 34.22 | 38.29 | 49.22 | 47.98 | |||||
LT Debt/Equity | 16.27 | 8.93 | 13.71 | 31.05 | 28.36 | |||||
Long-Term Debt / Total Capital | 10.74 | 5.88 | 8.46 | 15.76 | 14.75 | |||||
Total Liabilities / Total Assets | 39.2 | 39.58 | 42.92 | 52.66 | 53.61 | |||||
EBIT / Interest Expense | 15.48 | 20.13 | 10.42 | 4.48 | 4.08 | |||||
EBITDA / Interest Expense | 18.58 | 24.41 | 12.46 | 5.78 | 4.99 | |||||
(EBITDA - Capex) / Interest Expense | 8.87 | 10.28 | 1.83 | -1.06 | 1.14 | |||||
Total Debt / EBITDA | 1.89 | 1.98 | 2.36 | 3.74 | 3.35 | |||||
Net Debt / EBITDA | 1.48 | 1.81 | 2.15 | 3.35 | 3.17 | |||||
Total Debt / (EBITDA - Capex) | 3.96 | 4.71 | 16.04 | -20.46 | 14.71 | |||||
Net Debt / (EBITDA - Capex) | 3.11 | 4.3 | 14.6 | -18.32 | 13.92 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 9.09 | 17.7 | 41.5 | 28.21 | 17.02 | |||||
Gross Profit, 1 Yr. Growth % | 13.34 | 14.3 | 25.06 | 16.39 | 14.83 | |||||
EBITDA, 1 Yr. Growth % | 5.18 | 10.93 | 18.56 | 11.15 | 24.99 | |||||
EBITA, 1 Yr. Growth % | 5.25 | 9.86 | 20.45 | 3.18 | 31.69 | |||||
EBIT, 1 Yr. Growth % | 5.25 | 9.86 | 20.45 | 3.18 | 31.69 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 9.84 | 12.12 | 31.58 | -11.93 | 24.1 | |||||
Net Income, 1 Yr. Growth % | 9.84 | 12.12 | 31.58 | -11.93 | 24.1 | |||||
Normalized Net Income, 1 Yr. Growth % | 4.18 | 11.31 | 16.71 | -9.43 | 27.52 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 9.86 | 12.12 | 31.58 | -12.12 | 23.99 | |||||
Accounts Receivable, 1 Yr. Growth % | 11.35 | 7.03 | 38.13 | 12.55 | 38.94 | |||||
Inventory, 1 Yr. Growth % | 22.76 | 62.39 | 11.39 | 36.34 | 33.46 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 14.99 | 10.02 | 25.78 | 33.69 | 18.23 | |||||
Total Assets, 1 Yr. Growth % | 18.47 | 15.76 | 25.46 | 36.16 | 19.94 | |||||
Tangible Book Value, 1 Yr. Growth % | 17.12 | 15.03 | 18.51 | 11.79 | 17.53 | |||||
Common Equity, 1 Yr. Growth % | 17.12 | 15.03 | 18.51 | 11.79 | 17.53 | |||||
Cash From Operations, 1 Yr. Growth % | 88.44 | -41.05 | 70.58 | -68.04 | 423.12 | |||||
Capital Expenditures, 1 Yr. Growth % | 74.5 | 22.84 | 74.94 | 54.48 | -18.57 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -94.81 | 4.48T | 20.79 | 115.06 | -46.81 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -105.95 | -4.39T | 16.53 | 113.17 | -54.6 | |||||
Dividend Per Share, 1 Yr. Growth % | 14.29 | 25 | 10 | -18.18 | 11.11 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 7.32 | 13.31 | 29.05 | 34.69 | 22.49 | |||||
Gross Profit, 2 Yr. CAGR % | 16.4 | 12.69 | 19.56 | 20.65 | 15.6 | |||||
EBITDA, 2 Yr. CAGR % | 8.87 | 8.02 | 14.64 | 14.8 | 17.87 | |||||
EBITA, 2 Yr. CAGR % | 6.35 | 7.53 | 15.03 | 11.48 | 16.57 | |||||
EBIT, 2 Yr. CAGR % | 6.35 | 7.53 | 15.03 | 11.48 | 16.57 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 8.48 | 10.97 | 21.46 | 10.62 | 4.54 | |||||
Net Income, 2 Yr. CAGR % | 8.48 | 10.97 | 21.46 | 10.62 | 4.54 | |||||
Normalized Net Income, 2 Yr. CAGR % | 6.08 | 7.68 | 13.98 | 2.81 | 7.47 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 8.49 | 10.98 | 21.46 | 10.51 | 4.39 | |||||
Accounts Receivable, 2 Yr. CAGR % | 12.67 | 9.17 | 21.59 | 24.69 | 25.05 | |||||
Inventory, 2 Yr. CAGR % | 25.82 | 41.19 | 34.5 | 23.24 | 34.89 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 8.34 | 12.48 | 17.64 | 29.68 | 25.72 | |||||
Total Assets, 2 Yr. CAGR % | 12.15 | 17.11 | 20.51 | 30.7 | 27.79 | |||||
Tangible Book Value, 2 Yr. CAGR % | 13.85 | 16.07 | 16.76 | 15.69 | 14.62 | |||||
Common Equity, 2 Yr. CAGR % | 13.85 | 16.07 | 16.76 | 15.69 | 14.62 | |||||
Cash From Operations, 2 Yr. CAGR % | 2.83 | 5.42 | 7.72 | -30.98 | 29.3 | |||||
Capital Expenditures, 2 Yr. CAGR % | -19.96 | 46.41 | 46.59 | 64.39 | 12.16 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -52.29 | 54.13 | 651.23 | 61.51 | 6.95 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -46.82 | 59.69 | 614.18 | 57.97 | -1.62 | |||||
Dividend Per Share, 2 Yr. CAGR % | 6.9 | 19.52 | 17.26 | -5.13 | -4.65 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 3.1 | 10.67 | 22.02 | 28.77 | 28.52 | |||||
Gross Profit, 3 Yr. CAGR % | 13.89 | 14.93 | 16.67 | 18.49 | 18.67 | |||||
EBITDA, 3 Yr. CAGR % | 7.09 | 9.55 | 11.4 | 13.46 | 18.1 | |||||
EBITA, 3 Yr. CAGR % | 6 | 7.5 | 11.67 | 10.94 | 17.85 | |||||
EBIT, 3 Yr. CAGR % | 6 | 7.5 | 11.67 | 10.94 | 17.85 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 7.16 | 9.68 | 17.46 | 11.12 | 14.94 | |||||
Net Income, 3 Yr. CAGR % | 7.16 | 9.68 | 17.46 | 11.12 | 14.94 | |||||
Normalized Net Income, 3 Yr. CAGR % | 5.17 | 7.79 | 10.61 | 5.57 | 10.46 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 7.15 | 9.68 | 17.46 | 11.05 | 14.83 | |||||
Accounts Receivable, 3 Yr. CAGR % | 17.93 | 10.76 | 18.08 | 18.5 | 29.27 | |||||
Inventory, 3 Yr. CAGR % | 20.4 | 36.99 | 30.46 | 35.11 | 26.56 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 16.61 | 8.9 | 16.75 | 22.76 | 25.74 | |||||
Total Assets, 3 Yr. CAGR % | 16.41 | 13.34 | 19.83 | 25.52 | 27.01 | |||||
Tangible Book Value, 3 Yr. CAGR % | 13.69 | 14.24 | 16.88 | 15.47 | 16.3 | |||||
Common Equity, 3 Yr. CAGR % | 13.69 | 14.24 | 16.88 | 15.47 | 16.3 | |||||
Cash From Operations, 3 Yr. CAGR % | 5.58 | -14.57 | 29.82 | -31.32 | 35.57 | |||||
Capital Expenditures, 3 Yr. CAGR % | -15.56 | -7.67 | 55.36 | 49.18 | 30.07 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -67.73 | 118.48 | 43.04 | 395.81 | 11.54 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -67.19 | 129.74 | 44.76 | 378.01 | 4.25 | |||||
Dividend Per Share, 3 Yr. CAGR % | 16.96 | 12.62 | 16.26 | 4 | 0 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.97 | 8.47 | 12.78 | 19.72 | 22.21 | |||||
Gross Profit, 5 Yr. CAGR % | 11.69 | 12.07 | 15.66 | 17.18 | 16.24 | |||||
EBITDA, 5 Yr. CAGR % | 6.61 | 6.97 | 10.05 | 11.6 | 13.94 | |||||
EBITA, 5 Yr. CAGR % | 5.74 | 6.13 | 9.53 | 9.08 | 13.61 | |||||
EBIT, 5 Yr. CAGR % | 5.74 | 6.13 | 9.53 | 9.08 | 13.61 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 8.34 | 8.72 | 12.66 | 10.05 | 13.34 | |||||
Net Income, 5 Yr. CAGR % | 8.34 | 8.72 | 12.66 | 10.05 | 13.34 | |||||
Normalized Net Income, 5 Yr. CAGR % | 7.08 | 6.63 | 8.61 | 5.77 | 9.34 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 8.34 | 8.71 | 12.66 | 10.02 | 13.28 | |||||
Accounts Receivable, 5 Yr. CAGR % | 18.43 | 14.45 | 19.38 | 16.13 | 20.82 | |||||
Inventory, 5 Yr. CAGR % | 16.56 | 23.22 | 25.85 | 31.31 | 32.22 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 17.82 | 21.52 | 17.02 | 16.77 | 20.26 | |||||
Total Assets, 5 Yr. CAGR % | 17.42 | 19.53 | 18.03 | 19.99 | 22.95 | |||||
Tangible Book Value, 5 Yr. CAGR % | 16.36 | 14.76 | 14.91 | 14.82 | 16.21 | |||||
Common Equity, 5 Yr. CAGR % | 16.36 | 14.76 | 14.91 | 14.81 | 16.2 | |||||
Cash From Operations, 5 Yr. CAGR % | 1.2 | -0.21 | 6.44 | -19.28 | 26.16 | |||||
Capital Expenditures, 5 Yr. CAGR % | 12.13 | 57.66 | 5.29 | 16.29 | 36.38 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -34.31 | 42.39 | 13.66 | 94.38 | 27.45 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -35.48 | 38.5 | 12.49 | 98.59 | 24.15 | |||||
Dividend Per Share, 5 Yr. CAGR % | 9.86 | 14.87 | 17.08 | 5.15 | 7.39 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















